Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.740
-0.110 (-2.86%)
At close: Dec 5, 2025, 4:00 PM EST
3.850
+0.110 (2.94%)
After-hours: Dec 5, 2025, 7:58 PM EST
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $662.12 million as of December 5, 2025. Its market cap has increased by 63.18% in one year.
Market Cap
662.12M
Enterprise Value
566.97M
1-Year Change
63.18%
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $662.12M, a decrease of -59.31%. That is a compound annual growth rate of -25.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 681.60M | 82.94% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |